COVID-19 is having an unprecedented impact on the global pharmaceutical supply chain.

In this webinar, which focuses on current issues facing the global pharmaceutical supply chain, J.P. Duffy, Iqbal Hussain, and John Ellison will discuss the steps that companies should take now to position themselves for international arbitration claims that may arise from challenges such as export restrictions in India and decreased API manufacturing in China and elsewhere. The presenters will further examine clause drafting issues, the consequences of choosing common law over civil law as the governing law of the contract, how to select arbitrators for pharmaceutical supply chain disputes, and how companies should address indemnification obligations and insurance matters. CLE credit will be provided for various jurisdictions.

If you are in the pharmaceutical industry, or in any way included in or impacted by changes to pharmaceutical supply chains, this webinar is of relevance to you.